Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
FNCH

FNCH - Finch Therapeutics Group, Inc. Stock Price, Fair Value and News

$13.750.00 (0.00%)
Market Closed

27/100

FNCH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

27/100

FNCH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$11.43

Target 3M

$13.28

Target 6M

$12.33

FNCH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

FNCH Price Action

Last 7 days

-0.7%

Last 30 days

1.6%

Last 90 days

2.2%

Trailing 12 Months

19.6%

FNCH RSI Chart

FNCH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

FNCH Valuation

FNCH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$11.43

Target 3M

$13.28

Target 6M

$12.33

FNCH Fundamentals

FNCH Revenue

FNCH Earnings

FNCH Profitability

FNCH Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202401.5M00
2023541.8K831.5K1.1M1.4M
202214.0M9.4M4.8M252.0K
20219.5M10.0M19.5M18.5M
20200007.7M
Get all data in R, Python etc through our Historical Stock Data APIs

About Finch Therapeutics Group, Inc.

FNCH
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524, FIN-525, and other microbiome product candidates for inflammatory bowel disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.
 WEBSITEfinchtherapeutics.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES18

Finch Therapeutics Group, Inc. Frequently Asked Questions

FNCH is the stock ticker symbol of Finch Therapeutics Group, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

You can check FNCH's fair value in chart for subscribers.

The fair value guage provides a quick view whether FNCH is over valued or under valued. Whether Finch Therapeutics Group, Inc. is cheap or expensive depends on the assumptions which impact Finch Therapeutics Group, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for FNCH.